1. Home
  2. CRL vs BFAM Comparison

CRL vs BFAM Comparison

Compare CRL & BFAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRL
  • BFAM
  • Stock Information
  • Founded
  • CRL 1947
  • BFAM 1986
  • Country
  • CRL United States
  • BFAM United States
  • Employees
  • CRL N/A
  • BFAM N/A
  • Industry
  • CRL Biotechnology: Commercial Physical & Biological Resarch
  • BFAM Other Consumer Services
  • Sector
  • CRL Health Care
  • BFAM Consumer Discretionary
  • Exchange
  • CRL Nasdaq
  • BFAM Nasdaq
  • Market Cap
  • CRL 7.3B
  • BFAM 7.2B
  • IPO Year
  • CRL 2000
  • BFAM 1997
  • Fundamental
  • Price
  • CRL $156.68
  • BFAM $121.42
  • Analyst Decision
  • CRL Buy
  • BFAM Buy
  • Analyst Count
  • CRL 14
  • BFAM 8
  • Target Price
  • CRL $186.00
  • BFAM $138.25
  • AVG Volume (30 Days)
  • CRL 1.1M
  • BFAM 747.8K
  • Earning Date
  • CRL 08-06-2025
  • BFAM 07-31-2025
  • Dividend Yield
  • CRL N/A
  • BFAM N/A
  • EPS Growth
  • CRL N/A
  • BFAM 75.19
  • EPS
  • CRL N/A
  • BFAM 3.05
  • Revenue
  • CRL $4,028,615,000.00
  • BFAM $2,790,342,000.00
  • Revenue This Year
  • CRL N/A
  • BFAM $9.75
  • Revenue Next Year
  • CRL $2.49
  • BFAM $7.02
  • P/E Ratio
  • CRL N/A
  • BFAM $39.83
  • Revenue Growth
  • CRL N/A
  • BFAM 9.24
  • 52 Week Low
  • CRL $91.86
  • BFAM $103.75
  • 52 Week High
  • CRL $230.02
  • BFAM $141.90
  • Technical
  • Relative Strength Index (RSI)
  • CRL 47.73
  • BFAM 56.77
  • Support Level
  • CRL $145.99
  • BFAM $116.77
  • Resistance Level
  • CRL $168.61
  • BFAM $120.91
  • Average True Range (ATR)
  • CRL 5.10
  • BFAM 3.22
  • MACD
  • CRL -1.68
  • BFAM 0.54
  • Stochastic Oscillator
  • CRL 31.41
  • BFAM 52.78

About CRL Charles River Laboratories International Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

About BFAM Bright Horizons Family Solutions Inc.

Bright Horizons Family Solutions Inc provider of early education and child care, family care solutions, and workforce education services that help working families and client employees personally and professionally. It provides services under multi-year contracts with employers that offer early education and child care, back-up care, and educational advisory services as part of their employee benefits package. The company has three business segments; full-service center-based child care, backup care, and educational advisory services. The majority of the revenue is generated by full-service center-based child care, which includes traditional center-based child care and early education services. Other services provided by the company include in-home child and elder care, and Others.

Share on Social Networks: